Cystatin C-based CKD-EPI equations and N-terminal Pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure

Clinical Cardiology

Volumn 38, Issue 2, 2015, Pages 106-113

  Flores Blanco, Pedro J ^a   Manzano Fernández, Sergio ^a   Pérez Calvo, Juan I ^b,c   Pastor Pérez, Francisco J ^a   Ruiz Ruiz, Francisco J ^b   Carrasco Sánchez, Francisco J ^c   Morales Rull, José L ^d   Pascual Figal, Domingo ^a   Galisteo Almeda, Luis ^c   Januzzi, James L ^e  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CST3 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ASSESSMENT OF HUMANS; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; VERY ELDERLY; BIOLOGICAL MODEL; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; EVALUATION STUDY; HEART FAILURE; KAPLAN MEIER METHOD; KIDNEY; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; SPAIN; STATISTICAL MODEL; TIME;

AGED; AGED, 80 AND OVER; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SPAIN; TIME FACTORS;

EID: 84925411462     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22362     Document Type: Article

References (40)

1. Ezekowitz J, McAlister FA, Humphries KH, et al APPROACH Investigators. The association among renal insufficiency, pharmacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44:1587-1592.
2. Hillege HL, Nitsch D, Pfeffer MA, et al; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113:671-678.
3. Fonarow GC, Adams KF Jr, Abraham WT, et al ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580.
4. Abraham WT, Fonarow GC, Albert NM, et al OPTIMIZEHF Investigators and Coordinators. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52:347-356.
5. Levey AS, Stevens LA, Schmid CH, et al Chronic Kidney Disease Epidemiology Collaboration. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011;155:408]. Ann Intern Med. 2009;150:604-612.
6. Inker LA, Eckfeldt J, Levey AS, et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011;58:682-684.
7. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51:395-406.
8. Manzano-Fern ández S, Flores-Blanco PJ, P érez-Calvo JI, et al. Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure. J Card Fail. 2013;19:583-591.
9. Bruneau BG, Piazza LA, de Bold AJ. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol. 1997;273(6 part 2):H2678-H2686.
10. Maisel AS, Krishnaswamy P, Nowak RM, et al Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
11. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95:948-954.
12. Hartmann F, Packer M, Coats AJ, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation. 2004;110:1780-1786.
13. Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110:2168-2174.
14. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, et al. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail. 2005;11(5 suppl):S15-S20.
15. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-1140.
16. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
17. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527-1539.
18. Akhter MW, Aronson D, Bitar F, et al. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure [published correction appears in Am J Cardiol. 2005;96:324]. Am J Cardiol. 2004;94:957-960.
19. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987-1996.
20. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol. 2000;85:1110-1113.
21. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail. 2003;9: 13-25.
22. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8:136-141.
23. Adams KF Jr, Fonarow GC, Emerman CL, et al ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
24. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61-67.
25. Bart BA, Goldsmith SR, Lee KL, et al Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367:2296-2304.
26. Felker GM, Lee KL, Bull DA, et al NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797-805.
27. van Kimmenade RR, Januzzi JL Jr, Baggish AL, et al. Aminoterminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol. 2006;48:1621-1627.
28. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-1295.
29. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [published correction appears in N Engl J Med. 2008;18:4]. N Engl J Med. 2004;351:1296-1305.
30. Ruilope LM, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol. 2001;12:218-225.
31. Verhave JC, Gansevoort RT, Hillege HL, et al. Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. J Am Soc Nephrol. 2004;15:1316-1322.
32. Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the Modification of Diet in Renal Disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18:2749-2757.
33. Rule AD, Rodeheffer RJ, Larson TS, et al. Limitations of estimating glomerular filtration rate from serum creatinine in the general population [published correction appears in Mayo Clin Proc. 2006;81:1639]. Mayo Clin Proc. 2006;81:1427-1434.
34. Oh J, Kang SM, Hong N, et al; KorHF Registry. The CKD-EPI is more accurate in clinical outcome prediction thanMDRDequation in acute heart failure: data from the Korean Heart Failure (KorHF) Registry. Int J Cardiol. 2013;167:1084-1087.
35. Inker LA, Schmid CH, Tighiouart H, et al CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C [published corrections appear in N Engl J Med. 2012;367:681 and 2012;367:2060]. N Engl J Med. 2012;367:20-29.
36. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29-34.
37. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79-83.
38. McCullough PA, Duc P, Omland T, et al Breathing Not Properly Multinational Study Investigators. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly multinational study. Am J Kidney Dis. 2003;41:571-579.
39. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure and NT-proBNP measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Am Coll Cardiol. 2006;47:91-97.
40. Vanderheyden M, Bartunek J, Filippatos G, et al. Cardiovascular disease in patients with chronic renal impairment: role of natriuretic peptides. Congest Heart Fail. 2008;14(4 suppl 1):38-42.